A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2021; you can also visit the original URL.
The file type is application/pdf
.
Characteristics and predictors of early hospital deaths in newly diagnosed APL: a 13-year population-wide study
2021
Blood Advances
Despite therapeutic advances, early death (ED) remains a major factor curtailing survival of acute promyelocytic leukemia (APL). Studies examining factors that cause early death (ED; within 30 days of admission) and the correlation of survival with the timing of administration of all-trans retinoic acid (ATRA) and hemostatic parameters are scarce. We performed a cohort analysis of nonselect patients with newly diagnosed APL who presented to the health care system in Hong Kong, where oral
doi:10.1182/bloodadvances.2021004789
pmid:34269798
fatcat:7svqe2n7rzfota62vskdzo3bqq